鄂尔多斯(600295.SH)所在铁合金行业自2020年12月以来价格区间上移
格隆汇 3 月 3日丨鄂尔多斯(600295.SH)公布,公司股票于2021年3月1日、2日、3日连续三个交易日收盘价格涨幅偏离值累计达24.74%,自2021年2月10日至此次披露日,公司股票累计涨幅达91.92%,短期内公司股票股价涨幅较大,敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。
截至目前,公司不存在应披露而未披露的重大信息。
公司所在的铁合金行业方面,自2020年12月以来,受多方面因素影响,价格区间上移,近期有所波动,未来价格走势存在不确定性。
经公司自查,公司未发现对公司股票交易价格可能产生重大影响的媒体报道及市场传闻,亦未涉及市场热点概念。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.